Rank | Gene Set | Z-score |
---|---|---|
1 | lysine catabolic process (GO:0006554) | 5.19726372 |
2 | lysine metabolic process (GO:0006553) | 5.19726372 |
3 | L-phenylalanine metabolic process (GO:0006558) | 4.62891455 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.62891455 |
5 | 2-oxoglutarate metabolic process (GO:0006103) | 4.62521094 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.52455618 |
7 | L-phenylalanine catabolic process (GO:0006559) | 4.52455618 |
8 | glyoxylate metabolic process (GO:0046487) | 4.50043025 |
9 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.23583844 |
10 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.23480925 |
11 | fatty acid beta-oxidation (GO:0006635) | 4.18941246 |
12 | kynurenine metabolic process (GO:0070189) | 4.18543648 |
13 | carnitine shuttle (GO:0006853) | 4.14604791 |
14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.13493861 |
15 | fatty acid transmembrane transport (GO:1902001) | 4.11838223 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.00414027 |
17 | amino-acid betaine metabolic process (GO:0006577) | 3.97386679 |
18 | aromatic amino acid family catabolic process (GO:0009074) | 3.95471011 |
19 | sarcomere organization (GO:0045214) | 3.89825610 |
20 | phospholipid homeostasis (GO:0055091) | 3.89786607 |
21 | sulfur amino acid catabolic process (GO:0000098) | 3.89677867 |
22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.87511557 |
23 | aspartate family amino acid catabolic process (GO:0009068) | 3.87204002 |
24 | tricarboxylic acid metabolic process (GO:0072350) | 3.83776654 |
25 | fatty acid oxidation (GO:0019395) | 3.82813047 |
26 | serine family amino acid catabolic process (GO:0009071) | 3.78229217 |
27 | tricarboxylic acid cycle (GO:0006099) | 3.73613479 |
28 | regulation of cholesterol homeostasis (GO:2000188) | 3.73254970 |
29 | lipid oxidation (GO:0034440) | 3.72518846 |
30 | regulation of triglyceride catabolic process (GO:0010896) | 3.69161878 |
31 | homocysteine metabolic process (GO:0050667) | 3.68428399 |
32 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.67502517 |
33 | cysteine metabolic process (GO:0006534) | 3.66059367 |
34 | acetyl-CoA metabolic process (GO:0006084) | 3.65341988 |
35 | valine metabolic process (GO:0006573) | 3.64478587 |
36 | fatty acid catabolic process (GO:0009062) | 3.64471899 |
37 | indole-containing compound catabolic process (GO:0042436) | 3.55092823 |
38 | indolalkylamine catabolic process (GO:0046218) | 3.55092823 |
39 | tryptophan catabolic process (GO:0006569) | 3.55092823 |
40 | mannose metabolic process (GO:0006013) | 3.54348118 |
41 | ethanol oxidation (GO:0006069) | 3.52838877 |
42 | short-chain fatty acid metabolic process (GO:0046459) | 3.51875073 |
43 | negative regulation of fibrinolysis (GO:0051918) | 3.49115746 |
44 | tryptophan metabolic process (GO:0006568) | 3.47590204 |
45 | carnitine metabolic process (GO:0009437) | 3.47554176 |
46 | cardiac myofibril assembly (GO:0055003) | 3.42498649 |
47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.42041969 |
48 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.38670168 |
49 | monocarboxylic acid catabolic process (GO:0072329) | 3.37356217 |
50 | 4-hydroxyproline metabolic process (GO:0019471) | 3.37287340 |
51 | bile acid biosynthetic process (GO:0006699) | 3.36587073 |
52 | fatty acid homeostasis (GO:0055089) | 3.36123533 |
53 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.35130911 |
54 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.35069465 |
55 | urea metabolic process (GO:0019627) | 3.34452211 |
56 | urea cycle (GO:0000050) | 3.34452211 |
57 | regulation of fatty acid oxidation (GO:0046320) | 3.32964960 |
58 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.32175516 |
59 | glycine metabolic process (GO:0006544) | 3.32025184 |
60 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.29647038 |
61 | protein carboxylation (GO:0018214) | 3.29647038 |
62 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.29108496 |
63 | cellular ketone body metabolic process (GO:0046950) | 3.28140453 |
64 | oxaloacetate metabolic process (GO:0006107) | 3.27638182 |
65 | NADH metabolic process (GO:0006734) | 3.26068998 |
66 | positive regulation of fatty acid oxidation (GO:0046321) | 3.25351093 |
67 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.24817649 |
68 | triglyceride homeostasis (GO:0070328) | 3.23854559 |
69 | acylglycerol homeostasis (GO:0055090) | 3.23854559 |
70 | high-density lipoprotein particle remodeling (GO:0034375) | 3.22070821 |
71 | alpha-amino acid catabolic process (GO:1901606) | 3.21592737 |
72 | amino-acid betaine transport (GO:0015838) | 3.18865589 |
73 | carnitine transport (GO:0015879) | 3.18865589 |
74 | cellular modified amino acid catabolic process (GO:0042219) | 3.17253267 |
75 | carnitine transmembrane transport (GO:1902603) | 3.15866446 |
76 | regulation of protein activation cascade (GO:2000257) | 3.15247413 |
77 | regulation of sequestering of triglyceride (GO:0010889) | 3.14977206 |
78 | tyrosine metabolic process (GO:0006570) | 3.14823922 |
79 | detection of bacterium (GO:0016045) | 3.12610995 |
80 | biotin metabolic process (GO:0006768) | 3.11840202 |
81 | complement activation, alternative pathway (GO:0006957) | 3.11481260 |
82 | regulation of cholesterol metabolic process (GO:0090181) | 3.09783897 |
83 | epoxygenase P450 pathway (GO:0019373) | 3.09214670 |
84 | negative regulation of cholesterol transport (GO:0032375) | 3.09075764 |
85 | negative regulation of sterol transport (GO:0032372) | 3.09075764 |
86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.08119876 |
87 | aromatic amino acid family metabolic process (GO:0009072) | 3.07673858 |
88 | regulation of fibrinolysis (GO:0051917) | 3.06551897 |
89 | detection of other organism (GO:0098543) | 3.05130836 |
90 | cellular amino acid catabolic process (GO:0009063) | 3.04924686 |
91 | bile acid metabolic process (GO:0008206) | 3.04670600 |
92 | plasma lipoprotein particle clearance (GO:0034381) | 3.04030480 |
93 | cardiac muscle cell development (GO:0055013) | 3.03168363 |
94 | ketone body metabolic process (GO:1902224) | 3.02844915 |
95 | nitrogen cycle metabolic process (GO:0071941) | 3.01520315 |
96 | cholesterol homeostasis (GO:0042632) | 3.00750935 |
97 | organic acid catabolic process (GO:0016054) | 3.00605849 |
98 | carboxylic acid catabolic process (GO:0046395) | 3.00605849 |
99 | drug catabolic process (GO:0042737) | 3.00284030 |
100 | branched-chain amino acid metabolic process (GO:0009081) | 3.00199793 |
101 | phospholipid efflux (GO:0033700) | 2.98646821 |
102 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.98270517 |
103 | regulation of complement activation (GO:0030449) | 2.97455232 |
104 | response to peptidoglycan (GO:0032494) | 2.97450915 |
105 | sterol homeostasis (GO:0055092) | 2.97230450 |
106 | branched-chain amino acid catabolic process (GO:0009083) | 2.96617356 |
107 | intestinal cholesterol absorption (GO:0030299) | 2.96248940 |
108 | urate metabolic process (GO:0046415) | 2.95319410 |
109 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.93165040 |
110 | response to muramyl dipeptide (GO:0032495) | 2.89203506 |
111 | NIK/NF-kappaB signaling (GO:0038061) | 2.89183039 |
112 | germinal center formation (GO:0002467) | 2.80860392 |
113 | apoptotic process involved in morphogenesis (GO:0060561) | 2.78501897 |
114 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.77811375 |
115 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.77750240 |
116 | regulation of apoptotic cell clearance (GO:2000425) | 2.76592633 |
117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.69705978 |
118 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.69705978 |
119 | glycosphingolipid catabolic process (GO:0046479) | 2.68868907 |
120 | pinocytosis (GO:0006907) | 2.65026952 |
121 | response to laminar fluid shear stress (GO:0034616) | 2.64379842 |
122 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.63606870 |
123 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.61320388 |
124 | positive regulation by symbiont of host defense response (GO:0052509) | 2.59493391 |
125 | modulation by symbiont of host defense response (GO:0052031) | 2.59493391 |
126 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.59493391 |
127 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.59493391 |
128 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.59493391 |
129 | modulation by symbiont of host immune response (GO:0052553) | 2.59493391 |
130 | negative regulation of cell killing (GO:0031342) | 2.59110120 |
131 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.59110120 |
132 | regulation of gamma-delta T cell activation (GO:0046643) | 2.58625161 |
133 | barbed-end actin filament capping (GO:0051016) | 2.58175678 |
134 | macrophage activation involved in immune response (GO:0002281) | 2.57903958 |
135 | negative regulation of myotube differentiation (GO:0010832) | 2.55782377 |
136 | regulation of extracellular matrix disassembly (GO:0010715) | 2.55205791 |
137 | peptide catabolic process (GO:0043171) | 2.55073332 |
138 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.54641322 |
139 | atrioventricular valve morphogenesis (GO:0003181) | 2.53784049 |
140 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.53210474 |
141 | positive regulation of histone deacetylation (GO:0031065) | 2.51769751 |
142 | detection of external biotic stimulus (GO:0098581) | 2.50678688 |
143 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.46793655 |
144 | epithelial cell-cell adhesion (GO:0090136) | 2.46418066 |
145 | glycolipid catabolic process (GO:0019377) | 2.44665920 |
146 | cell-cell junction maintenance (GO:0045217) | 2.41813523 |
147 | negative regulation of granulocyte differentiation (GO:0030853) | 2.41809270 |
148 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.41349315 |
149 | plasma lipoprotein particle assembly (GO:0034377) | 2.40742480 |
150 | immunoglobulin mediated immune response (GO:0016064) | 2.40009538 |
151 | positive regulation of lipid catabolic process (GO:0050996) | 2.39403413 |
152 | angiotensin maturation (GO:0002003) | 2.39147086 |
153 | semaphorin-plexin signaling pathway (GO:0071526) | 2.37839285 |
154 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.36747855 |
155 | regulation of leukocyte degranulation (GO:0043300) | 2.36006329 |
156 | protein-lipid complex assembly (GO:0065005) | 2.35949646 |
157 | complement activation, classical pathway (GO:0006958) | 2.35892580 |
158 | regulation of extracellular matrix organization (GO:1903053) | 2.35575146 |
159 | regulation of cholesterol storage (GO:0010885) | 2.33791900 |
160 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.32845590 |
161 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.32204998 |
162 | ethanol metabolic process (GO:0006067) | 2.31364141 |
163 | regulation of cholesterol esterification (GO:0010872) | 2.31103129 |
164 | acute-phase response (GO:0006953) | 2.31063120 |
165 | positive thymic T cell selection (GO:0045059) | 2.29332115 |
166 | complement activation (GO:0006956) | 2.29055042 |
167 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.28998143 |
168 | glucose 6-phosphate metabolic process (GO:0051156) | 2.28277008 |
169 | desmosome organization (GO:0002934) | 2.28214579 |
170 | negative regulation of fatty acid transport (GO:2000192) | 2.27550615 |
171 | negative regulation of viral release from host cell (GO:1902187) | 2.24391184 |
172 | positive regulation of receptor recycling (GO:0001921) | 2.23997901 |
173 | detection of biotic stimulus (GO:0009595) | 2.22651280 |
174 | activation of MAPKKK activity (GO:0000185) | 2.20414278 |
175 | protein localization to endosome (GO:0036010) | 2.20094750 |
176 | adhesion of symbiont to host (GO:0044406) | 2.20035569 |
177 | thymic T cell selection (GO:0045061) | 2.19345562 |
178 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.19022269 |
179 | cellular response to virus (GO:0098586) | 2.18975536 |
180 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.18956392 |
181 | positive regulation of extracellular matrix organization (GO:1903055) | 2.17824046 |
182 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.17586961 |
183 | response to type I interferon (GO:0034340) | 2.17575442 |
184 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.17422541 |
185 | modulation by symbiont of host cellular process (GO:0044068) | 2.17391858 |
186 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.16000178 |
187 | positive regulation of protein deacetylation (GO:0090312) | 2.15825425 |
188 | neutrophil activation involved in immune response (GO:0002283) | 2.14289822 |
189 | regulation of necroptotic process (GO:0060544) | 2.12692794 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.73288757 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.05791914 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.95320178 |
4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.77233740 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.03862225 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.18226451 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.76873263 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.74441630 |
9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.71017031 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.50472483 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.45458960 |
12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.39746358 |
13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07602949 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96878223 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.91852021 |
16 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91055151 |
17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.86830385 |
18 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86569436 |
19 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.84510953 |
20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.81769110 |
21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.73143340 |
22 | MYC_22102868_ChIP-Seq_BL_Human | 1.70664175 |
23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.70138202 |
24 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66934997 |
25 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.64911795 |
26 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.61438568 |
27 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.61438568 |
28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59834888 |
29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59169223 |
30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56147569 |
31 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54001489 |
32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.52651849 |
33 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47644775 |
34 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.46863968 |
35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.46054979 |
36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45360126 |
37 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43704437 |
38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43242145 |
39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39852595 |
40 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38729844 |
41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37403631 |
42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37206824 |
43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36700472 |
44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35322702 |
45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34817926 |
46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34469673 |
47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33901076 |
48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33813933 |
49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31985265 |
50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31859754 |
51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30946717 |
52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29967482 |
53 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29080814 |
54 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27848794 |
55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27772723 |
56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27064046 |
57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26104519 |
58 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26029957 |
59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25776997 |
60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25463720 |
61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23800225 |
62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22997224 |
63 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22935348 |
64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22697025 |
65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21540573 |
66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21536200 |
67 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.21129455 |
68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21061362 |
69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20993203 |
70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19901309 |
71 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19710865 |
72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18336842 |
73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17459375 |
74 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16790167 |
75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16703482 |
76 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16174718 |
77 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16121977 |
78 | MAF_26560356_Chip-Seq_TH2_Human | 1.15775519 |
79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15049259 |
80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14779943 |
81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13436088 |
82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12171350 |
83 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11678454 |
84 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11357247 |
85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11278433 |
86 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11109946 |
87 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10692076 |
88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10592931 |
89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10177648 |
90 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08460228 |
91 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07815692 |
92 | MAF_26560356_Chip-Seq_TH1_Human | 1.07594273 |
93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06946269 |
94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06473482 |
95 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05675304 |
96 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05621396 |
97 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.05174411 |
98 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.03945054 |
99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03810396 |
100 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03708102 |
101 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03522233 |
102 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02848927 |
103 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02677720 |
104 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01364530 |
105 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01074996 |
106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00581520 |
107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00258944 |
108 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00122167 |
109 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00069856 |
110 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99857374 |
111 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.99809571 |
112 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99664744 |
113 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99589209 |
114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98768299 |
115 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98616718 |
116 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97196781 |
117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95820277 |
118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95612529 |
119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93688392 |
120 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92041014 |
121 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.91852954 |
122 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91467566 |
123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90632430 |
124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89834034 |
125 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89335676 |
126 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.87776318 |
127 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.87776318 |
128 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.87776318 |
129 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87247254 |
130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87059388 |
131 | * P68_20966046_ChIP-Seq_HELA_Human | 0.85347746 |
132 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.85018614 |
133 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.84552897 |
134 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84511672 |
135 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84142796 |
136 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83611903 |
137 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.83390263 |
138 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83237089 |
139 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83129599 |
140 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82452790 |
141 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80994533 |
142 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.79877796 |
143 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.79850370 |
144 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.79694754 |
145 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.77253230 |
146 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.76952230 |
147 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.75129745 |
148 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.74561582 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.68880947 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.60501167 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.77973435 |
4 | MP0005365_abnormal_bile_salt | 3.71659516 |
5 | MP0002837_dystrophic_cardiac_calcinosis | 3.66336133 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.11432150 |
7 | MP0004084_abnormal_cardiac_muscle | 2.90333534 |
8 | MP0009840_abnormal_foam_cell | 2.87530280 |
9 | MP0003252_abnormal_bile_duct | 2.81579309 |
10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.72224342 |
11 | MP0003436_decreased_susceptibility_to | 2.66544339 |
12 | MP0003303_peritoneal_inflammation | 2.60511451 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.50319638 |
14 | MP0010329_abnormal_lipoprotein_level | 2.21508570 |
15 | MP0005330_cardiomyopathy | 2.14784590 |
16 | MP0003172_abnormal_lysosome_physiology | 2.12459814 |
17 | MP0005670_abnormal_white_adipose | 2.05667124 |
18 | MP0003646_muscle_fatigue | 2.01948550 |
19 | MP0005409_darkened_coat_color | 1.96021035 |
20 | MP0004215_abnormal_myocardial_fiber | 1.94577940 |
21 | MP0010155_abnormal_intestine_physiology | 1.91999674 |
22 | MP0005083_abnormal_biliary_tract | 1.88129176 |
23 | MP0009278_abnormal_bone_marrow | 1.82258157 |
24 | MP0005076_abnormal_cell_differentiation | 1.80402742 |
25 | MP0001666_abnormal_nutrient_absorption | 1.78364874 |
26 | MP0005332_abnormal_amino_acid | 1.78052467 |
27 | MP0004947_skin_inflammation | 1.76460774 |
28 | MP0004036_abnormal_muscle_relaxation | 1.75962787 |
29 | MP0003724_increased_susceptibility_to | 1.75204803 |
30 | MP0000751_myopathy | 1.74542264 |
31 | MP0008260_abnormal_autophagy | 1.73717938 |
32 | MP0005025_abnormal_response_to | 1.73189875 |
33 | MP0003195_calcinosis | 1.71484775 |
34 | MP0004130_abnormal_muscle_cell | 1.71277930 |
35 | MP0000609_abnormal_liver_physiology | 1.69615990 |
36 | MP0003191_abnormal_cellular_cholesterol | 1.67855900 |
37 | MP0002419_abnormal_innate_immunity | 1.67354089 |
38 | MP0003453_abnormal_keratinocyte_physiol | 1.64536149 |
39 | MP0000685_abnormal_immune_system | 1.64143849 |
40 | MP0004858_abnormal_nervous_system | 1.64043815 |
41 | MP0001873_stomach_inflammation | 1.61460468 |
42 | MP0010630_abnormal_cardiac_muscle | 1.61154518 |
43 | MP0002254_reproductive_system_inflammat | 1.59704234 |
44 | MP0001790_abnormal_immune_system | 1.57997637 |
45 | MP0005387_immune_system_phenotype | 1.57997637 |
46 | MP0001835_abnormal_antigen_presentation | 1.56974858 |
47 | MP0005666_abnormal_adipose_tissue | 1.55408623 |
48 | MP0004087_abnormal_muscle_fiber | 1.51167157 |
49 | MP0005319_abnormal_enzyme/_coenzyme | 1.50767254 |
50 | MP0009785_altered_susceptibility_to | 1.48329992 |
51 | MP0002269_muscular_atrophy | 1.47670411 |
52 | MP0010368_abnormal_lymphatic_system | 1.45107986 |
53 | MP0000858_altered_metastatic_potential | 1.44398020 |
54 | MP0006082_CNS_inflammation | 1.43063343 |
55 | MP0008775_abnormal_heart_ventricle | 1.41361119 |
56 | MP0001544_abnormal_cardiovascular_syste | 1.38237459 |
57 | MP0005385_cardiovascular_system_phenoty | 1.38237459 |
58 | MP0002118_abnormal_lipid_homeostasis | 1.38152068 |
59 | MP0003566_abnormal_cell_adhesion | 1.35810729 |
60 | MP0002148_abnormal_hypersensitivity_rea | 1.34009054 |
61 | MP0002998_abnormal_bone_remodeling | 1.33629542 |
62 | MP0001533_abnormal_skeleton_physiology | 1.32824335 |
63 | * MP0009643_abnormal_urine_homeostasis | 1.32704454 |
64 | MP0002138_abnormal_hepatobiliary_system | 1.32126637 |
65 | MP0000750_abnormal_muscle_regeneration | 1.31297882 |
66 | MP0005000_abnormal_immune_tolerance | 1.30958141 |
67 | MP0002972_abnormal_cardiac_muscle | 1.29870043 |
68 | MP0004185_abnormal_adipocyte_glucose | 1.27393147 |
69 | MP0001800_abnormal_humoral_immune | 1.26953720 |
70 | MP0003183_abnormal_peptide_metabolism | 1.26722456 |
71 | MP0000749_muscle_degeneration | 1.26388700 |
72 | MP0003866_abnormal_defecation | 1.25757493 |
73 | MP0006138_congestive_heart_failure | 1.25557664 |
74 | MP0009333_abnormal_splenocyte_physiolog | 1.25301811 |
75 | MP0004019_abnormal_vitamin_homeostasis | 1.24144677 |
76 | MP0005464_abnormal_platelet_physiology | 1.23840618 |
77 | MP0010352_gastrointestinal_tract_polyps | 1.22757776 |
78 | MP0000604_amyloidosis | 1.20178362 |
79 | MP0002452_abnormal_antigen_presenting | 1.19489510 |
80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.19327300 |
81 | MP0006036_abnormal_mitochondrial_physio | 1.16833027 |
82 | MP0002723_abnormal_immune_serum | 1.14588816 |
83 | MP0003075_altered_response_to | 1.14348682 |
84 | MP0008469_abnormal_protein_level | 1.13635819 |
85 | MP0003763_abnormal_thymus_physiology | 1.13298711 |
86 | MP0005671_abnormal_response_to | 1.13255382 |
87 | MP0003828_pulmonary_edema | 1.12749781 |
88 | MP0003878_abnormal_ear_physiology | 1.12698486 |
89 | MP0005377_hearing/vestibular/ear_phenot | 1.12698486 |
90 | MP0000678_abnormal_parathyroid_gland | 1.12689294 |
91 | MP0004510_myositis | 1.12030528 |
92 | MP0002166_altered_tumor_susceptibility | 1.11758998 |
93 | MP0008004_abnormal_stomach_pH | 1.11281966 |
94 | MP0001845_abnormal_inflammatory_respons | 1.11113935 |
95 | MP0003091_abnormal_cell_migration | 1.08627381 |
96 | MP0005310_abnormal_salivary_gland | 1.07688228 |
97 | MP0005397_hematopoietic_system_phenotyp | 1.05808294 |
98 | MP0001545_abnormal_hematopoietic_system | 1.05808294 |
99 | MP0001819_abnormal_immune_cell | 1.05608091 |
100 | MP0003300_gastrointestinal_ulcer | 1.04168433 |
101 | MP0002420_abnormal_adaptive_immunity | 1.04155248 |
102 | MP0002127_abnormal_cardiovascular_syste | 1.04118175 |
103 | MP0004381_abnormal_hair_follicle | 1.03504281 |
104 | MP0002405_respiratory_system_inflammati | 1.03396789 |
105 | MP0003567_abnormal_fetal_cardiomyocyte | 1.02800027 |
106 | MP0005375_adipose_tissue_phenotype | 1.02736681 |
107 | MP0002796_impaired_skin_barrier | 1.02633587 |
108 | MP0000598_abnormal_liver_morphology | 1.01020118 |
109 | MP0002877_abnormal_melanocyte_morpholog | 0.99499282 |
110 | MP0005166_decreased_susceptibility_to | 0.99234193 |
111 | MP0003137_abnormal_impulse_conducting | 0.99121620 |
112 | MP0000490_abnormal_crypts_of | 0.98665212 |
113 | MP0001851_eye_inflammation | 0.98098541 |
114 | MP0002132_abnormal_respiratory_system | 0.96875049 |
115 | MP0002933_joint_inflammation | 0.95835403 |
116 | MP0000343_altered_response_to | 0.95659426 |
117 | MP0000566_synostosis | 0.89969814 |
118 | MP0005620_abnormal_muscle_contractility | 0.87478908 |
119 | MP0000249_abnormal_blood_vessel | 0.87202453 |
120 | MP0003329_amyloid_beta_deposits | 0.86823580 |
121 | MP0001663_abnormal_digestive_system | 0.86822866 |
122 | MP0004264_abnormal_extraembryonic_tissu | 0.86161839 |
123 | MP0003279_aneurysm | 0.84835647 |
124 | MP0004043_abnormal_pH_regulation | 0.83799112 |
125 | MP0002106_abnormal_muscle_physiology | 0.83775333 |
126 | MP0002078_abnormal_glucose_homeostasis | 0.82216346 |
127 | MP0000716_abnormal_immune_system | 0.80368206 |
128 | MP0005451_abnormal_body_composition | 0.80240679 |
129 | MP0001853_heart_inflammation | 0.80093239 |
130 | MP0005023_abnormal_wound_healing | 0.78511192 |
131 | MP0002088_abnormal_embryonic_growth/wei | 0.78366897 |
132 | MP0002396_abnormal_hematopoietic_system | 0.77471011 |
133 | MP0000266_abnormal_heart_morphology | 0.77431850 |
134 | MP0003984_embryonic_growth_retardation | 0.77234191 |
135 | MP0000465_gastrointestinal_hemorrhage | 0.76544710 |
136 | MP0005266_abnormal_metabolism | 0.74964933 |
137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74897113 |
138 | MP0001756_abnormal_urination | 0.74672841 |
139 | MP0008961_abnormal_basal_metabolism | 0.72091068 |
140 | MP0003283_abnormal_digestive_organ | 0.70448730 |
141 | MP0002971_abnormal_brown_adipose | 0.70245452 |
142 | MP0009763_increased_sensitivity_to | 0.69355757 |
143 | MP0000747_muscle_weakness | 0.69109398 |
144 | MP0002128_abnormal_blood_circulation | 0.68255849 |
145 | MP0003868_abnormal_feces_composition | 0.68140224 |
146 | MP0001672_abnormal_embryogenesis/_devel | 0.67617745 |
147 | MP0005380_embryogenesis_phenotype | 0.67617745 |
148 | MP0005058_abnormal_lysosome_morphology | 0.64987180 |
149 | MP0000003_abnormal_adipose_tissue | 0.62920121 |
150 | MP0001849_ear_inflammation | 0.62580299 |
151 | MP0004484_altered_response_of | 0.61660709 |
152 | MP0010234_abnormal_vibrissa_follicle | 0.61354390 |
153 | MP0009642_abnormal_blood_homeostasis | 0.61210875 |
154 | MP0000767_abnormal_smooth_muscle | 0.61037270 |
155 | MP0005334_abnormal_fat_pad | 0.60880005 |
156 | MP0003186_abnormal_redox_activity | 0.60787562 |
157 | MP0004085_abnormal_heartbeat | 0.60680168 |
158 | MP0002086_abnormal_extraembryonic_tissu | 0.60356600 |
159 | MP0006035_abnormal_mitochondrial_morpho | 0.60054811 |
160 | MP0000371_diluted_coat_color | 0.59798915 |
161 | MP0005369_muscle_phenotype | 0.59048364 |
162 | MP0009053_abnormal_anal_canal | 0.58668444 |
163 | MP0001661_extended_life_span | 0.57453364 |
164 | MP0005165_increased_susceptibility_to | 0.57338891 |
165 | MP0000759_abnormal_skeletal_muscle | 0.57201729 |
166 | MP0005187_abnormal_penis_morphology | 0.56452268 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic coma (HP:0001325) | 4.90518011 |
2 | Systemic lupus erythematosus (HP:0002725) | 4.56134680 |
3 | Ventricular tachycardia (HP:0004756) | 4.45812502 |
4 | Right ventricular cardiomyopathy (HP:0011663) | 4.33305131 |
5 | Sudden death (HP:0001699) | 4.30395192 |
6 | Intrahepatic cholestasis (HP:0001406) | 4.21270124 |
7 | Xanthomatosis (HP:0000991) | 4.17599071 |
8 | Deep venous thrombosis (HP:0002625) | 4.07862580 |
9 | Hyperglycinuria (HP:0003108) | 4.04792371 |
10 | Ketosis (HP:0001946) | 3.91709614 |
11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.89126258 |
12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.88441011 |
13 | Ketoacidosis (HP:0001993) | 3.81358437 |
14 | Hyperammonemia (HP:0001987) | 3.80409329 |
15 | Eczematoid dermatitis (HP:0000976) | 3.69013446 |
16 | Hemorrhage of the eye (HP:0011885) | 3.65506860 |
17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.63671757 |
18 | Myoglobinuria (HP:0002913) | 3.55253804 |
19 | Abnormality of glycine metabolism (HP:0010895) | 3.50360295 |
20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.50360295 |
21 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.30201081 |
22 | Hypoalphalipoproteinemia (HP:0003233) | 3.29753257 |
23 | Hypobetalipoproteinemia (HP:0003563) | 3.28766639 |
24 | Malnutrition (HP:0004395) | 3.28214566 |
25 | Hyperglycinemia (HP:0002154) | 3.23632351 |
26 | Dicarboxylic aciduria (HP:0003215) | 3.17826781 |
27 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.17826781 |
28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.16445036 |
29 | Hypolipoproteinemia (HP:0010981) | 3.14460501 |
30 | Hyperlipoproteinemia (HP:0010980) | 3.13658949 |
31 | Palpitations (HP:0001962) | 3.13613415 |
32 | Glomerulonephritis (HP:0000099) | 3.12529542 |
33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.10001006 |
34 | Lipoatrophy (HP:0100578) | 3.03710252 |
35 | Increased cerebral lipofuscin (HP:0011813) | 3.00038173 |
36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98507783 |
37 | Muscle fiber splitting (HP:0003555) | 2.95192031 |
38 | Asymmetric septal hypertrophy (HP:0001670) | 2.90884400 |
39 | Abnormality of macrophages (HP:0004311) | 2.90701748 |
40 | Hyporeflexia of lower limbs (HP:0002600) | 2.84655660 |
41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.83269961 |
42 | Atrioventricular block (HP:0001678) | 2.82408107 |
43 | Dysostosis multiplex (HP:0000943) | 2.80006461 |
44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.79448819 |
45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.79448819 |
46 | Abnormality of glycolipid metabolism (HP:0010969) | 2.79448819 |
47 | Complement deficiency (HP:0004431) | 2.78190748 |
48 | Syncope (HP:0001279) | 2.77642613 |
49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.74229707 |
50 | Dilated cardiomyopathy (HP:0001644) | 2.73662877 |
51 | Atrial fibrillation (HP:0005110) | 2.73496456 |
52 | Hyperglycemia (HP:0003074) | 2.73457307 |
53 | Increased connective tissue (HP:0009025) | 2.73339557 |
54 | Hypoglycemic seizures (HP:0002173) | 2.71447132 |
55 | Skin nodule (HP:0200036) | 2.71207837 |
56 | Epidermoid cyst (HP:0200040) | 2.69687818 |
57 | Gout (HP:0001997) | 2.68284330 |
58 | Rhabdomyolysis (HP:0003201) | 2.68059765 |
59 | Generalized aminoaciduria (HP:0002909) | 2.68058693 |
60 | Late onset (HP:0003584) | 2.67912490 |
61 | Thin bony cortex (HP:0002753) | 2.67045757 |
62 | Distal lower limb muscle weakness (HP:0009053) | 2.66732480 |
63 | Exercise-induced muscle cramps (HP:0003710) | 2.65538058 |
64 | Bundle branch block (HP:0011710) | 2.63348805 |
65 | Broad face (HP:0000283) | 2.60572569 |
66 | Flat acetabular roof (HP:0003180) | 2.60543134 |
67 | Colitis (HP:0002583) | 2.60404581 |
68 | Prolonged partial thromboplastin time (HP:0003645) | 2.59882843 |
69 | Axonal loss (HP:0003447) | 2.57784900 |
70 | Recurrent abscess formation (HP:0002722) | 2.57754825 |
71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.56336528 |
72 | Loss of speech (HP:0002371) | 2.55924096 |
73 | Multiple enchondromatosis (HP:0005701) | 2.50624642 |
74 | Obstructive sleep apnea (HP:0002870) | 2.48630343 |
75 | Primary atrial arrhythmia (HP:0001692) | 2.47752157 |
76 | Cerebral aneurysm (HP:0004944) | 2.47056637 |
77 | Mucopolysacchariduria (HP:0008155) | 2.46960875 |
78 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46960875 |
79 | Hypercholesterolemia (HP:0003124) | 2.45511761 |
80 | Abnormality of purine metabolism (HP:0004352) | 2.45006262 |
81 | Purpura (HP:0000979) | 2.43556617 |
82 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41575792 |
83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41575792 |
84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41575792 |
85 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.40235724 |
86 | Heart block (HP:0012722) | 2.38685239 |
87 | Supraventricular tachycardia (HP:0004755) | 2.37997593 |
88 | Supraventricular arrhythmia (HP:0005115) | 2.37452877 |
89 | Abnormality of the nasal mucosa (HP:0000433) | 2.37412097 |
90 | Abnormal cartilage morphology (HP:0002763) | 2.36825383 |
91 | Gingivitis (HP:0000230) | 2.36685077 |
92 | Recurrent bacterial skin infections (HP:0005406) | 2.35641201 |
93 | Ventricular arrhythmia (HP:0004308) | 2.34861751 |
94 | Esophageal varix (HP:0002040) | 2.31659741 |
95 | Abnormality of the common coagulation pathway (HP:0010990) | 2.30932692 |
96 | Abnormality of the intrinsic pathway (HP:0010989) | 2.27977941 |
97 | Metabolic acidosis (HP:0001942) | 2.27891107 |
98 | Nephritis (HP:0000123) | 2.26641403 |
99 | Distal lower limb amyotrophy (HP:0008944) | 2.26539680 |
100 | Myositis (HP:0100614) | 2.25548127 |
101 | Abnormal atrioventricular conduction (HP:0005150) | 2.24387176 |
102 | Hepatocellular carcinoma (HP:0001402) | 2.24292291 |
103 | Abnormality of nucleobase metabolism (HP:0010932) | 2.23950309 |
104 | Exercise-induced myalgia (HP:0003738) | 2.22651879 |
105 | Myocardial infarction (HP:0001658) | 2.22361804 |
106 | Stroke (HP:0001297) | 2.22110007 |
107 | Thoracic kyphosis (HP:0002942) | 2.21355789 |
108 | Calf muscle hypertrophy (HP:0008981) | 2.20888583 |
109 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.20789584 |
110 | Subaortic stenosis (HP:0001682) | 2.20789584 |
111 | Lymphangioma (HP:0100764) | 2.19510443 |
112 | Increased IgE level (HP:0003212) | 2.19263199 |
113 | Polygenic inheritance (HP:0010982) | 2.19254164 |
114 | Gastrointestinal inflammation (HP:0004386) | 2.18867009 |
115 | Increased serum ferritin (HP:0003281) | 2.17913409 |
116 | Vacuolated lymphocytes (HP:0001922) | 2.16947926 |
117 | Joint hemorrhage (HP:0005261) | 2.16815456 |
118 | Amyloidosis (HP:0011034) | 2.15462748 |
119 | Nausea (HP:0002018) | 2.13726172 |
120 | Testicular atrophy (HP:0000029) | 2.10907368 |
121 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.10646715 |
122 | Abnormality of the thoracic spine (HP:0100711) | 2.10188701 |
123 | Polycythemia (HP:0001901) | 2.10153670 |
124 | Abnormality of the calf musculature (HP:0001430) | 2.08691942 |
125 | Fat malabsorption (HP:0002630) | 2.08426002 |
126 | Proximal tubulopathy (HP:0000114) | 2.07377905 |
127 | Abnormality of the fingertips (HP:0001211) | 2.06173951 |
128 | Orchitis (HP:0100796) | 2.05964073 |
129 | Spontaneous hematomas (HP:0007420) | 2.04656564 |
130 | Nasal polyposis (HP:0100582) | 2.03280374 |
131 | Ragged-red muscle fibers (HP:0003200) | 2.02949442 |
132 | Cellulitis (HP:0100658) | 2.02944218 |
133 | Lethargy (HP:0001254) | 2.00002286 |
134 | Spastic diplegia (HP:0001264) | 1.99833212 |
135 | Abnormality of methionine metabolism (HP:0010901) | 1.98614175 |
136 | Abnormality of serum amino acid levels (HP:0003112) | 1.98396143 |
137 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98346538 |
138 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98149204 |
139 | Inflammation of the large intestine (HP:0002037) | 1.97414239 |
140 | Abnormality of complement system (HP:0005339) | 1.96281932 |
141 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.95744817 |
142 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.95744817 |
143 | Interstitial pulmonary disease (HP:0006530) | 1.92709577 |
144 | Cervical subluxation (HP:0003308) | 1.91223124 |
145 | Hyperuricemia (HP:0002149) | 1.90597827 |
146 | Increased purine levels (HP:0004368) | 1.90597827 |
147 | Hyperbilirubinemia (HP:0002904) | 1.89876663 |
148 | Bone pain (HP:0002653) | 1.89865893 |
149 | Hypertriglyceridemia (HP:0002155) | 1.89730797 |
150 | Neonatal death (HP:0003811) | 1.89251791 |
151 | Aneurysm (HP:0002617) | 1.89165735 |
152 | Abnormality of proline metabolism (HP:0010907) | 1.87315977 |
153 | Hydroxyprolinuria (HP:0003080) | 1.87315977 |
154 | Insulin resistance (HP:0000855) | 1.87054983 |
155 | J-shaped sella turcica (HP:0002680) | 1.84915829 |
156 | Difficulty climbing stairs (HP:0003551) | 1.84618549 |
157 | Abdominal distention (HP:0003270) | 1.84532543 |
158 | Cholelithiasis (HP:0001081) | 1.84432720 |
159 | Easy fatigability (HP:0003388) | 1.84100624 |
160 | Pustule (HP:0200039) | 1.83862752 |
161 | Distal upper limb amyotrophy (HP:0007149) | 1.81395276 |
162 | Upper limb amyotrophy (HP:0009129) | 1.81395276 |
163 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81303751 |
164 | Pathologic fracture (HP:0002756) | 1.80775768 |
165 | Obstructive lung disease (HP:0006536) | 1.79703475 |
166 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79703475 |
167 | Mediastinal lymphadenopathy (HP:0100721) | 1.78452542 |
168 | Hyperacusis (HP:0010780) | 1.78025843 |
169 | Metaphyseal cupping (HP:0003021) | 1.76479964 |
170 | Nuclear cataract (HP:0100018) | 1.76466277 |
171 | Epistaxis (HP:0000421) | 1.74324212 |
172 | Bulbar palsy (HP:0001283) | 1.72761648 |
173 | Abnormality of iron homeostasis (HP:0011031) | 1.71524201 |
174 | Hypophosphatemia (HP:0002148) | 1.71488404 |
175 | Prolonged bleeding time (HP:0003010) | 1.70322952 |
176 | Diaphragmatic weakness (HP:0009113) | 1.68874133 |
177 | Recurrent fungal infections (HP:0002841) | 1.68338738 |
178 | Meningitis (HP:0001287) | 1.66352880 |
179 | Gastrointestinal infarctions (HP:0005244) | 1.65634591 |
180 | Elevated alkaline phosphatase (HP:0003155) | 1.63371096 |
181 | Abnormal vertebral ossification (HP:0100569) | 1.63293493 |
182 | Neurofibrillary tangles (HP:0002185) | 1.62552922 |
183 | Gingival bleeding (HP:0000225) | 1.60727420 |
184 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.60635562 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PKN2 | 3.83416081 |
2 | TRIB3 | 3.76672043 |
3 | TTN | 3.53465198 |
4 | BCKDK | 3.26672711 |
5 | PRPF4B | 2.70429832 |
6 | FGFR4 | 2.67324894 |
7 | ERN1 | 2.66002229 |
8 | SMG1 | 2.61360130 |
9 | IRAK3 | 2.51641473 |
10 | RIPK1 | 2.45977940 |
11 | MAP3K10 | 2.22036753 |
12 | SIK1 | 2.19352314 |
13 | LMTK2 | 2.02008913 |
14 | NEK1 | 1.99162613 |
15 | FLT3 | 1.95103496 |
16 | CDK12 | 1.93561663 |
17 | TAOK1 | 1.85090553 |
18 | INSRR | 1.71798621 |
19 | PTK6 | 1.71779167 |
20 | PDK4 | 1.67727749 |
21 | PDK3 | 1.67727749 |
22 | KDR | 1.61155782 |
23 | MYLK | 1.59947249 |
24 | PDGFRA | 1.51620665 |
25 | MAP3K3 | 1.49888691 |
26 | MAP3K13 | 1.48157069 |
27 | TIE1 | 1.45936560 |
28 | BLK | 1.43913720 |
29 | EPHA2 | 1.41797452 |
30 | RIPK4 | 1.39042555 |
31 | TNK2 | 1.36340674 |
32 | TGFBR2 | 1.35750070 |
33 | MARK2 | 1.35686170 |
34 | MAP3K14 | 1.31772886 |
35 | MAP4K1 | 1.30289773 |
36 | LATS1 | 1.26357515 |
37 | MAP2K3 | 1.24418410 |
38 | ICK | 1.21574766 |
39 | IRAK4 | 1.17648650 |
40 | DMPK | 1.17302427 |
41 | EEF2K | 1.17148493 |
42 | MAP3K1 | 1.15904072 |
43 | STK10 | 1.13261031 |
44 | TYK2 | 1.12888094 |
45 | PRKD2 | 1.11391723 |
46 | TAOK2 | 1.02355457 |
47 | STK38L | 1.00738990 |
48 | PDK2 | 0.99997123 |
49 | MTOR | 0.99375055 |
50 | PHKG2 | 0.99154329 |
51 | PHKG1 | 0.99154329 |
52 | IKBKE | 0.96351938 |
53 | MST1R | 0.94826651 |
54 | STK4 | 0.93543881 |
55 | EPHB1 | 0.93375321 |
56 | FGFR3 | 0.92181869 |
57 | CSF1R | 0.88873192 |
58 | MAP3K7 | 0.88121336 |
59 | BMX | 0.86791730 |
60 | PDPK1 | 0.85291629 |
61 | GRK6 | 0.84194174 |
62 | JAK1 | 0.83876269 |
63 | PRKAA2 | 0.83165727 |
64 | OBSCN | 0.82475709 |
65 | RPS6KA2 | 0.81320669 |
66 | HIPK2 | 0.81306463 |
67 | MATK | 0.80869582 |
68 | CDK4 | 0.80610746 |
69 | CHUK | 0.80471162 |
70 | MAPK11 | 0.80208849 |
71 | LRRK2 | 0.79764672 |
72 | PRKAA1 | 0.77229058 |
73 | IRAK2 | 0.77164036 |
74 | ITK | 0.76964362 |
75 | PRKD1 | 0.76543952 |
76 | CSK | 0.75988982 |
77 | CAMK1D | 0.75566096 |
78 | PTK2 | 0.75100790 |
79 | WNK4 | 0.74986691 |
80 | MAPK15 | 0.74981286 |
81 | DDR2 | 0.72353109 |
82 | JAK2 | 0.71933073 |
83 | NEK9 | 0.70992135 |
84 | PAK3 | 0.70203139 |
85 | FGR | 0.70075733 |
86 | MAP3K6 | 0.69864219 |
87 | MET | 0.68795617 |
88 | ZAP70 | 0.67998310 |
89 | DYRK1B | 0.67060053 |
90 | BTK | 0.67023329 |
91 | MAPK7 | 0.64453951 |
92 | IRAK1 | 0.62491283 |
93 | NME2 | 0.61672774 |
94 | CDK6 | 0.61094910 |
95 | CDC42BPA | 0.60834843 |
96 | KIT | 0.60685216 |
97 | FES | 0.59460352 |
98 | PAK4 | 0.58933869 |
99 | PASK | 0.58442619 |
100 | MAP3K8 | 0.57079633 |
101 | TAOK3 | 0.56539311 |
102 | IKBKB | 0.56299401 |
103 | NEK2 | 0.55909853 |
104 | SIK3 | 0.55840988 |
105 | TBK1 | 0.55804436 |
106 | JAK3 | 0.55447982 |
107 | MAPKAPK3 | 0.55403648 |
108 | TESK2 | 0.54981864 |
109 | STK24 | 0.54376453 |
110 | RPS6KC1 | 0.54167976 |
111 | RPS6KL1 | 0.54167976 |
112 | MAPK12 | 0.53148262 |
113 | PDK1 | 0.52863848 |
114 | TESK1 | 0.52480411 |
115 | MAP2K2 | 0.52399191 |
116 | RET | 0.52128666 |
117 | EPHA3 | 0.52076411 |
118 | TGFBR1 | 0.51217970 |
119 | MARK3 | 0.50509986 |
120 | GSK3A | 0.50395073 |
121 | PRKG2 | 0.50291219 |
122 | NLK | 0.49287297 |
123 | HCK | 0.47564763 |
124 | RPS6KA4 | 0.46959977 |
125 | RPS6KA6 | 0.46172213 |
126 | TTK | 0.44889824 |
127 | MAP3K11 | 0.42887967 |
128 | LCK | 0.42500262 |
129 | SIK2 | 0.42276740 |
130 | CAMK4 | 0.42069833 |
131 | MAP3K5 | 0.40754209 |
132 | STK38 | 0.40205691 |
133 | PIM1 | 0.39203681 |
134 | BRD4 | 0.38936451 |
135 | EPHB2 | 0.37334605 |
136 | FGFR1 | 0.35639389 |
137 | RPS6KA1 | 0.35297820 |
138 | RPS6KB2 | 0.35247913 |
139 | STK3 | 0.34135377 |
140 | PDGFRB | 0.33200245 |
141 | CAMK1G | 0.33078967 |
142 | LYN | 0.32879066 |
143 | PRKACG | 0.31142959 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.55965855 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.30809651 |
3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.25499159 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.13805500 |
5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.99840628 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.83180825 |
7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.76646398 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66094095 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.65056927 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.64007792 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61750953 |
12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.40702146 |
13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39357907 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.23540060 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06173800 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.98980322 |
17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.96689021 |
18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81996723 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77679810 |
20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.73312232 |
21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.71087302 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69144223 |
23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68350989 |
24 | Lysine degradation_Homo sapiens_hsa00310 | 1.65066882 |
25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.64255777 |
26 | Peroxisome_Homo sapiens_hsa04146 | 1.63558775 |
27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.62112990 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62102682 |
29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58295237 |
30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.56940268 |
31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.48827795 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47966865 |
33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47101548 |
34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44904151 |
35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34787157 |
36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.32602056 |
37 | Bile secretion_Homo sapiens_hsa04976 | 1.32357173 |
38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31281623 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.31221548 |
40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28902022 |
41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26724982 |
42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.23952610 |
43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23225333 |
44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21227544 |
45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19419978 |
46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18356464 |
47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18347906 |
48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17822258 |
49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.17617811 |
50 | Hepatitis C_Homo sapiens_hsa05160 | 1.16026969 |
51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15628609 |
52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11195716 |
53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09637360 |
54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09437079 |
55 | ABC transporters_Homo sapiens_hsa02010 | 1.09066932 |
56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08214864 |
57 | Pertussis_Homo sapiens_hsa05133 | 1.06742676 |
58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05693206 |
59 | Allograft rejection_Homo sapiens_hsa05330 | 1.05642507 |
60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05128544 |
61 | Influenza A_Homo sapiens_hsa05164 | 1.04866500 |
62 | Tuberculosis_Homo sapiens_hsa05152 | 1.04653717 |
63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01147071 |
64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00373594 |
65 | Insulin resistance_Homo sapiens_hsa04931 | 0.99747971 |
66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99163004 |
67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95984467 |
68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93875032 |
69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91162149 |
70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90875953 |
71 | Amoebiasis_Homo sapiens_hsa05146 | 0.90249200 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89944371 |
73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89373940 |
74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89089426 |
75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87968717 |
76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87877561 |
77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87320748 |
78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83045547 |
79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80092308 |
80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79957294 |
81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79924095 |
82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78898075 |
83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77615909 |
84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76895886 |
85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76079183 |
86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75829606 |
87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74464091 |
88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74361564 |
89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73250127 |
90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73010329 |
91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71805649 |
92 | Malaria_Homo sapiens_hsa05144 | 0.71594348 |
93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71530786 |
94 | Bladder cancer_Homo sapiens_hsa05219 | 0.71474363 |
95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71389147 |
96 | Asthma_Homo sapiens_hsa05310 | 0.70916208 |
97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70379669 |
98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69950862 |
99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69718368 |
100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69627788 |
101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67778790 |
102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64975543 |
103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64248303 |
104 | Salmonella infection_Homo sapiens_hsa05132 | 0.63945575 |
105 | Apoptosis_Homo sapiens_hsa04210 | 0.61938329 |
106 | Hepatitis B_Homo sapiens_hsa05161 | 0.60706851 |
107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60598265 |
108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60443408 |
109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59655644 |
110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59559291 |
111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59243798 |
112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58403769 |
113 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58228042 |
114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57578794 |
115 | Platelet activation_Homo sapiens_hsa04611 | 0.57379455 |
116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56883051 |
117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56450014 |
118 | Measles_Homo sapiens_hsa05162 | 0.55552979 |
119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53967301 |
120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53706595 |
121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52803593 |
122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52669111 |
123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52210069 |
124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51932264 |
125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51783167 |
126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51688137 |
127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51665815 |
128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51027934 |
129 | Legionellosis_Homo sapiens_hsa05134 | 0.50961731 |
130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47272381 |
131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45877481 |
132 | Adherens junction_Homo sapiens_hsa04520 | 0.40366692 |
133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32678259 |
134 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32282557 |
135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31248724 |
136 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30511677 |
137 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.28036314 |
138 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25978588 |
139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25379287 |
140 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25290102 |
141 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24414379 |
142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22184009 |
143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20050806 |
144 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.19595624 |
145 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19584940 |
146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18971911 |
147 | Focal adhesion_Homo sapiens_hsa04510 | 0.17051029 |
148 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.16541192 |
149 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.12821366 |
150 | Prion diseases_Homo sapiens_hsa05020 | 0.12737623 |
151 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12334440 |
152 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11462948 |
153 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.10702685 |
154 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.09006994 |
155 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08065816 |
156 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07935591 |
157 | Tight junction_Homo sapiens_hsa04530 | 0.06886638 |